Latest Regulatory Approval News

INOVIQ Limited reported a $6.9 million net loss for FY25 while making significant strides in its exosome-based cancer diagnostics and therapeutics pipeline, including a breakthrough ovarian cancer screening test and promising CAR-exosome therapy results.

Peninsula Energy outlines a revised production roadmap for its Lance uranium project in Wyoming, addressing commissioning delays and legacy contract burdens while securing fresh capital to fuel growth amid strong US nuclear energy momentum.

Peninsula Energy Limited launches a fully underwritten A$69.9 million equity raising to support the ramp-up of its Lance uranium project in Wyoming, alongside a strategic operational reset and leadership overhaul.

Peninsula Energy has raised nearly A$70 million through a fully underwritten equity raise to fund a strategic reset and ramp-up of its Lance uranium project in Wyoming, accompanied by a significant revision to production guidance.

Piedmont Lithium has released an updated timetable for its merger with Sayona Mining, marking key dates for stockholder approval, trading suspensions, and the final merger close by late August 2025.

Omnia Metals Group Limited has issued a prospectus to list up to 10,000 options, aiming to remove trading restrictions and facilitate secondary market activity. This move follows recent capital raisings and shareholder approvals, positioning the company for enhanced liquidity.

Cue Energy Resources reported a 10.4% increase in revenue to $54.8 million for FY2025, driven by stable production and higher gas prices, but net profit after tax halved to $6.32 million due to rising costs. The company declared a final dividend of 0.5 cents per share.

BCI Minerals has transitioned to full-scale operations at its Mardie Salt Project, marking a pivotal moment with strong construction progress, secured financing, and binding offtake agreements. The company remains on track for first salt shipment by late 2026.

Arovella Therapeutics reported a 14% reduction in net loss to $7.5 million for FY25, bolstered by a $15 million capital raise to fund its lead iNKT cell therapy program progressing toward a pivotal phase 1 clinical trial.

Cuscal Limited has reported a strong FY25 performance exceeding its Prospectus forecasts and announced a $75 million cash acquisition of Indue Limited, aiming to create a more resilient and competitive payments business.

Brazilian Critical Minerals secures robust support from Amazonas state and local authorities for its Ema Rare Earth Project, advancing environmental permitting with unanimous community approval.

Cuscal Limited has exceeded its FY25 profit expectations and announced a strategic $75 million acquisition of Indue Limited, aiming to boost scale and efficiency in the Australian payments sector.